Post-earnings recap
Reported
Thu, May 6, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Techne Corp reported a strong earnings per share, beating expectations significantly. However, the stock fell by 1.4% in reaction, likely due to the lack of revenue details and forward guidance. Investors may be cautious given the ongoing supply chain issues mentioned by management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.79 | N/A | +44.35% |
| Revenue | N/A | N/A | N/A |
Management conveyed a cautiously optimistic outlook, emphasizing strong product performance. They acknowledged supply chain challenges but remain focused on growth.
Management highlighted strong performance in key product lines.
They noted ongoing challenges in the supply chain but remain focused on growth.
The team expressed confidence in long-term strategies despite current market conditions.